🟡 60/100

Review before taking

  • Total Iodide/Iodine: 12.5mg is 11.4× the Tolerable Upper Intake Level (1.1mg)
  • 100% of ingredients have research evidence
C Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Total Iodide/Iodine: 12.5mg is 11.4× the Tolerable Upper Intake Level (1.1mg)

The safety score is low because the amount of iodine in this supplement is more than 11 times higher than the recommended maximum daily limit.

Label Data

1 Tablet(s) Serving Size
Mineral Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

12.5 mg (8333% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 11.4× (UL: 1.1 mg) 📚 243 studies (Tier A: 4, B: 133)
RDA 0.15mg This product: 12.5mg UL 1.1mg

Other Ingredients

Micosolle Microcrystalline Cellulose Vegetable Stearins Pharmaceutical Glaze

Label Claims — Verification

All Other
All Other (98% of products) Structure/Function (74% of products) Nutrient (53% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Suggested Use: As a dietary supplement, take one tablet per day or as directed by a physician.

⚠️ Warnings & Precautions

Warning: If pregnant or nursing, consult your healthcare practitioner before use. Do not us if you have an iodine sensitivity, or if you are taking anti-hypertension or anti-thyroid medications.

Keep out of reach of children.

Discontinue use if you develop swollen salivary glands, stomach upset, or skin rash.

🧪 Formulation Notes

Provides Iodine as Iodine and Potassium Iodide.

High Potency Iodine/Potassium Iodide

Variations in product color may occur.

Additional Information

Store in a cool, dry and dark place.

Product Details

UPC / SKU 3 50520 01501 6
DSLD Entry Date 2020-03-24
Product Type Mineral
Form Tablet or Pill
Brand Optimox
DSLD ID 214232
Data Updated 2026-04-11

Research Evidence

292 Research Sources
57 Avg Quality Score
160 Meta Analysis
70 Systematic Review
36 Rct
8 Cochrane Review
8 Clinical Trial
3 Regulatory Source
2 Narrative Review
2 Other
1 Guideline
1 Openfda Safety
A Umbilical cord antiseptics for preventing sepsis and death among newborns
Meta Analysis The Cochrane database of systematic reviews 2026
A Food fortification with multiple micronutrients: impact on health outcomes in general population
Meta Analysis The Cochrane database of systematic reviews 2019
A Interventions for cutaneous molluscum contagiosum
Meta Analysis The Cochrane database of systematic reviews 2017
A Chlorhexidine vs Povidone-Iodine and Incidence of Catheter-Related Infections: A Systematic Review and Meta-Analysis
Meta Analysis JAMA network open 2026
B Radioiodine Remnant Ablation for Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis
Meta Analysis JAMA otolaryngology-- head & neck surgery 2021
B Risk of primary breast cancer in patients with differentiated thyroid cancer undergoing radioactive iodine therapy: a systematic review and meta-analysis
Meta Analysis European journal of nuclear medicine and molecular imaging 2022
B Alcoholic chlorhexidine skin preparation or triclosan-coated sutures to reduce surgical site infection: a systematic review and meta-analysis of high-quality randomised controlled trials
Meta Analysis The Lancet. Infectious diseases 2022
B Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia
Meta Analysis The Cochrane database of systematic reviews 2013
B Interventions for ingrowing toenails
Meta Analysis The Cochrane database of systematic reviews 2012
B Interventions for the management of malignant pleural effusions: a network meta-analysis
Systematic Review The Cochrane database of systematic reviews 2016
View all evidence for Iodine →

Compare Similar Products

View all Iodine products →